ProfileGDS4718 / 222547_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 34% 48% 21% 38% 54% 40% 29% 33% 39% 43% 49% 18% 50% 54% 39% 47% 38% 37% 49% 32% 34% 49% 40% 47% 54% 34% 26% 38% 44% 54% 72% 30% 32% 53% 53% 43% 38% 36% 61% 37% 47% 67% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7586335
GSM549102patient 115, normal, homogenized [OPG study]4.740134
GSM549104patient 119, normal, homogenized [OPG study]5.406248
GSM549108patient 138, normal, homogenized [OPG study]4.2067421
GSM549119patient 077, normal, homogenized [OPG study]4.9175538
GSM549133patient 032, cancer, homogenized [OPG study]5.7239654
GSM549139patient 042, cancer, homogenized [OPG study]4.9758840
GSM549099patient 107, normal, homogenized [OPG study]4.5040329
GSM549109patient 139, normal, homogenized [OPG study]4.699333
GSM549110patient 046, normal, homogenized [OPG study]4.9623839
GSM549114patient 063, normal, homogenized [OPG study]5.1055243
GSM549122patient 082, normal, homogenized [OPG study]5.4690149
GSM549134patient 033, cancer, homogenized [OPG study]4.0487218
GSM549136patient 036, cancer, homogenized [OPG study]5.4551450
GSM549140patient 044, cancer, homogenized [OPG study]5.731354
GSM549111patient 047, normal, homogenized [OPG study]4.9357239
GSM549113patient 057, normal, homogenized [OPG study]5.3091947
GSM549132patient 031, cancer, homogenized [OPG study]4.8690838
GSM549137patient 038, cancer, homogenized [OPG study]4.8243237
GSM549142patient 047, cancer, homogenized [OPG study]5.6006649
GSM549100patient 110, normal, homogenized [OPG study]4.6524432
GSM549107patient 135, normal, homogenized [OPG study]4.6787634
GSM549115patient 068, normal, homogenized [OPG study]5.3756249
GSM549116patient 072, normal, homogenized [OPG study]4.9527740
GSM549120patient 078, normal, homogenized [OPG study]5.3656547
GSM549131patient 030, cancer, homogenized [OPG study]5.7173554
GSM549118patient 074, normal, homogenized [OPG study]4.7021434
GSM549129patient 027, cancer, homogenized [OPG study]4.3743226
GSM549123patient 088, normal, homogenized [OPG study]4.8592338
GSM549124patient 006, cancer, homogenized [OPG study]5.2283844
GSM549126patient 015, cancer, homogenized [OPG study]5.7150854
GSM549128patient 025, cancer, homogenized [OPG study]7.1620472
GSM549103patient 117, normal, homogenized [OPG study]4.5815630
GSM549117patient 073, normal, homogenized [OPG study]4.6169132
GSM549138patient 041, cancer, homogenized [OPG study]5.7129553
GSM549141patient 045, cancer, homogenized [OPG study]5.6453753
GSM549130patient 028, cancer, homogenized [OPG study]5.1261943
GSM549101patient 111, normal, homogenized [OPG study]4.9530638
GSM549105patient 128, normal, homogenized [OPG study]4.8176836
GSM549106patient 134, normal, homogenized [OPG study]6.1976661
GSM549112patient 048, normal, homogenized [OPG study]4.8206937
GSM549125patient 011, cancer, homogenized [OPG study]5.3750247
GSM549127patient 024, cancer, homogenized [OPG study]6.7393167
GSM549135patient 035, cancer, homogenized [OPG study]7.082172